Adenosine A2A antagonists as neurotherapeutics: crossing the bridge.
Schwarzschild
Michael A
MA
MassGeneral Institute for Neurodegenerative Disease, Boston, USA. MichaelS@helix.mgh.harvard.edu
D058917:Adenosine A2 Receptor Antagonists; D000818:Animals; D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D043705:Receptor, Adenosine A2A / Q000378:metabolism
D058917:Adenosine A2 Receptor Antagonists; D018696:Neuroprotective Agents; D043705:Receptor, Adenosine A2A